Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Immunologic and epidemiologic drivers of norovirus transmission in daycare and school outbreaks

Joshua Havumaki, Joseph NS Eisenberg, Claire P Mattison, Benjamin A Lopman, Ismael R Ortega-Sanchez, Aron J Hall, David W Hutton, Marisa C Eisenberg
doi: https://doi.org/10.1101/2019.12.19.19015396
Joshua Havumaki
1Department of Epidemiology; University of Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: joshsh@umich.edu marisae@umich.edu
Joseph NS Eisenberg
1Department of Epidemiology; University of Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claire P Mattison
2National Center for Immunization and Respiratory Diseases, Division of Viral Diseases; Centers for Disease Control and Prevention
3Oak Ridge Institute for Science and Education
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin A Lopman
4Department of Epidemiology, Emory University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ismael R Ortega-Sanchez
2National Center for Immunization and Respiratory Diseases, Division of Viral Diseases; Centers for Disease Control and Prevention
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aron J Hall
2National Center for Immunization and Respiratory Diseases, Division of Viral Diseases; Centers for Disease Control and Prevention
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David W Hutton
5Departments of Health Management and Policy, Industrial and Operations Engineering; University of Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marisa C Eisenberg
6Departments of Epidemiology, Mathematics, Complex Systems; University of Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: joshsh@umich.edu marisae@umich.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

1 Abstract

Background Norovirus outbreaks are notoriously explosive, with dramatic symptomology and rapid disease spread. Children are particularly vulnerable to infection and drive norovirus transmission due to their high contact rates with each other and the environment. Despite the explosive nature of norovirus outbreaks, attack rates in schools and daycares remain low with the majority of students not reporting symptoms.

Methods We explore immunologic and epidemiologic mechanisms that may underlie epidemic norovirus transmission dynamics using a disease transmission model. Towards this end, we compared different model scenarios, including innate resistance and acquired immunity (collectively denoted ‘immunity’), stochastic extinction, and an individual exclusion intervention. We calibrated our model to daycare and school outbreaks from national surveillance data.

Results Recreating the low attack rates observed in daycare and school outbreaks required a model with immunity. However, immunity alone resulted in shorter duration outbreaks than what was observed. The addition of individual exclusion (to the immunity model) extended outbreak durations by reducing the amount of time that symptomatic people contribute to transmission. Including both immunity and individual exclusion mechanisms resulted in simulations where both attack rates and outbreak durations were consistent with surveillance data.

Conclusions The epidemiology of norovirus outbreaks in daycare and school settings cannot be well described by a simple transmission model in which all individuals start as fully susceptible. Interventions should leverage population immunity and encourage more rigorous individual exclusion to improve venue-level control measures.

Competing Interest Statement

Dr. Lopman reports personal fees from Takeda Pharmaceuticals, CDC Foundation, and Hall Booth Smith, P.C. outside the submitted work.

Funding Statement

This Study was funded by the Joint Initiative for Vaccine Economics, Phase 5, a cooperative agreement between the University of Michigan and the Centers for Disease Control and Prevention (U01IP000965). Additionally, this study was funded by the National Institute of General Medical Sciences (U01GM110712).

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The surveillance datasets are available from the Centers for Disease Control and Prevention upon request and application. Computing code available from the corresponding author upon reasonable request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted December 21, 2019.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Immunologic and epidemiologic drivers of norovirus transmission in daycare and school outbreaks
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Immunologic and epidemiologic drivers of norovirus transmission in daycare and school outbreaks
Joshua Havumaki, Joseph NS Eisenberg, Claire P Mattison, Benjamin A Lopman, Ismael R Ortega-Sanchez, Aron J Hall, David W Hutton, Marisa C Eisenberg
medRxiv 2019.12.19.19015396; doi: https://doi.org/10.1101/2019.12.19.19015396
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Immunologic and epidemiologic drivers of norovirus transmission in daycare and school outbreaks
Joshua Havumaki, Joseph NS Eisenberg, Claire P Mattison, Benjamin A Lopman, Ismael R Ortega-Sanchez, Aron J Hall, David W Hutton, Marisa C Eisenberg
medRxiv 2019.12.19.19015396; doi: https://doi.org/10.1101/2019.12.19.19015396

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (179)
  • Allergy and Immunology (431)
  • Anesthesia (99)
  • Cardiovascular Medicine (942)
  • Dentistry and Oral Medicine (178)
  • Dermatology (109)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (418)
  • Epidemiology (8968)
  • Forensic Medicine (4)
  • Gastroenterology (418)
  • Genetic and Genomic Medicine (1938)
  • Geriatric Medicine (190)
  • Health Economics (400)
  • Health Informatics (1322)
  • Health Policy (657)
  • Health Systems and Quality Improvement (517)
  • Hematology (211)
  • HIV/AIDS (416)
  • Infectious Diseases (except HIV/AIDS) (10766)
  • Intensive Care and Critical Care Medicine (570)
  • Medical Education (199)
  • Medical Ethics (52)
  • Nephrology (221)
  • Neurology (1818)
  • Nursing (108)
  • Nutrition (271)
  • Obstetrics and Gynecology (351)
  • Occupational and Environmental Health (469)
  • Oncology (992)
  • Ophthalmology (296)
  • Orthopedics (111)
  • Otolaryngology (182)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (576)
  • Pharmacology and Therapeutics (275)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1891)
  • Public and Global Health (4108)
  • Radiology and Imaging (674)
  • Rehabilitation Medicine and Physical Therapy (362)
  • Respiratory Medicine (547)
  • Rheumatology (224)
  • Sexual and Reproductive Health (190)
  • Sports Medicine (177)
  • Surgery (206)
  • Toxicology (38)
  • Transplantation (109)
  • Urology (80)